We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$97.4M
AUM Growth
+$22M
Cap. Flow
+$20.5M
Cap. Flow %
21.05%
Top 10 Hldgs %
87.15%
Holding
39
New
24
Increased
1
Reduced
2
Closed
12

Sector Composition

Rank Sector Weight
1 Financials 18.77%
2 Materials 18.44%
3 Consumer Discretionary 11.2%
4 Consumer Staples 9.73%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
1
CALL
Kraft Heinz
KHC
$30.4B
$16.9M 17.35%
+218,000
New +$18.2M
GGAL icon
2
Galicia Financial Group
GGAL
$7.92B
$15.8M 16.26%
+307,314
New +$13.1M
EWZ icon
3
iShares MSCI Brazil ETF
EWZ
$9.05B
$10.4M 10.7%
+250,000
New +$9.78M
KHC icon
4
Kraft Heinz
KHC
$30.4B
$9.48M 9.73%
+122,292
New +$10.2M
MELI icon
5
Mercado Libre
MELI
$91.3B
$9.17M 9.41%
+35,400
New +$9.38M
NGD
6
DELISTED
New Gold Inc
NGD
$8.16M 8.38%
+2,200,000
New +$7.6M
VALE icon
7
Vale
VALE
$62.9B
$5.75M 5.9%
+570,760
New +$5.74M
AGI icon
8
Alamos Gold
AGI
$12.4B
$4.06M 4.16%
+600,000
New +$4.42M
INCY icon
9
Incyte
INCY
$23.5B
$2.68M 2.75%
22,938
-362
-2% -$45.8K
BMA icon
10
Banco Macro
BMA
$5.7B
$2.45M 2.52%
+20,900
New +$2.03M
NETS
11
DELISTED
Netshoes (Cayman) Limited
NETS
$1.75M 1.79%
+133,000
New +$2.16M
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.72M 1.77%
18,506
-758
-4% -$67K
AZUL
13
DELISTED
Azul
AZUL
$1.51M 1.55%
+54,900
New +$1.41M
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
$1.12M 1.15%
20,603
+969
+5% +$49.6K
EWZ icon
15
PUT
iShares MSCI Brazil ETF
EWZ
$9.05B
$675K 0.69%
+16,200
New +$634K
AERI
16
DELISTED
Aerie Pharmaceuticals
AERI
$673K 0.69%
+13,844
New +$755K
BMY icon
17
Bristol-Myers Squibb
BMY
$127B
$659K 0.68%
+10,340
New +$604K
FOLD
18
DELISTED
Amicus Therapeutics
FOLD
$570K 0.59%
+37,773
New +$500K
EXEL icon
19
Exelixis
EXEL
$13.9B
$534K 0.55%
+22,020
New +$586K
ASMB icon
20
Assembly Biosciences
ASMB
$506M
$510K 0.52%
+1,216
New +$373K
BSX icon
21
Boston Scientific
BSX
$65.8B
$446K 0.46%
+15,302
New +$423K
ACAD icon
22
Acadia Pharmaceuticals
ACAD
$4.25B
$437K 0.45%
+11,607
New +$378K
EPZM
23
DELISTED
Epizyme, Inc
EPZM
$292K 0.3%
+15,333
New +$234K
VXX
24
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$90K 0.09%
+2,300
New +$107K
VXX
25
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$90K 0.09%
+2,300
New +$107K

Similar funds

JGP Global Gestao de Recursos's Q3 2017 Portfolio in Review

As of Q3 2017, JGP Global Gestao de Recursos held 39 positions worth $97.4M, up 29% from $75.4M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

JGP Global Gestao de Recursos deployed $20.5M of net new capital in Q3 2017, opening 24 new positions and adding to 1 existing holding. Its largest new stake was Galicia Financial Group: 307,314 shares worth $15.8M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Materials and Consumer Discretionary.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $67K trimmed.

  • JGP Global Gestao de Recursos's largest Q3 2017 buy was Galicia Financial Group: 307,314 shares worth $15.8M.
  • JGP Global Gestao de Recursos added most to Seagen Inc. Common Stock in Q3 2017, an estimated $49.6K increase.
  • JGP Global Gestao de Recursos's biggest Q3 2017 reduction was BioMarin Pharmaceuticals, cutting an estimated $67K.
  • JGP Global Gestao de Recursos fully exited Celgene Corp in Q3 2017, selling an estimated $1.47M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 87% of its $97.4M portfolio in Q3 2017.
  • JGP Global Gestao de Recursos opened 24 new positions and closed 12 in Q3 2017.
  • JGP Global Gestao de Recursos's portfolio value rose 29% quarter-over-quarter to $97.4M.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2017, filed 9 Nov 2017.